Literature DB >> 10630988

Protein-carbohydrate interactions in human lysozyme probed by combining site-directed mutagenesis and affinity labeling.

M Muraki1, K Harata, N Sugita, K I Sato.   

Abstract

The synergism between apolar and polar interactions in the carbohydrate recognition by human lysozyme (HL) was probed by site-directed mutagenesis and affinity labeling. The three-dimensional structures of the Tyr63-->Leu mutant HL labeled with 2',3'-epoxypropyl beta-glycoside of N,N'-diacetylchitobiose (L63-HL/NAG-NAG-EPO complex) and the Asp102-->Glu mutant HL labeled with the 2',3'-epoxypropyl beta-glycoside of N-acetyllactosamine were revealed by X-ray diffraction at 2.23 and 1.96 A resolution, respectively. Compared to the wild-type HL labeled with the 2', 3'-epoxypropyl beta-glycoside of N,N'-diacetylchitobiose, the N-acetylglucosamine residue at subsite B of the L63-HL/NAG-NAG-EPO complex markedly moved away from the 63rd residue, with substantial loss of hydrogen-bonding interactions. Evidently, the stacking interaction with the aromatic side chain of Tyr63 is essential in positioning the N-acetylglucosamine residue in the productive binding mode. On the other hand, the position of the galactose residue in subsite B of HL is almost unchanged by the mutation of Asp102 to Glu. Most hydrogen bonds, including the one between the carboxylate group of Glu102 and the axial 4-OH group of the galactose residue, were maintained by local movement of the backbone from residues 102-104. In both structures, the conformation of the disaccharide was conserved, reflecting an intrinsic conformational rigidity of the disaccharides. The structural analysis suggested that CH-pi interactions played an important role in the recognition of the carbohydrate residue at subsite B of HL.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10630988     DOI: 10.1021/bi991402q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Modelling of carbohydrate-aromatic interactions: ab initio energetics and force field performance.

Authors:  Vojtech Spiwok; Petra Lipovová; Tereza Skálová; Eva Vondrácková; Jan Dohnálek; Jindrich Hasek; Blanka Králová
Journal:  J Comput Aided Mol Des       Date:  2006-04-11       Impact factor: 3.686

2.  Carbohydrate recognition by RpfB from Mycobacterium tuberculosis unveiled by crystallographic and molecular dynamics analyses.

Authors:  Flavia Squeglia; Maria Romano; Alessia Ruggiero; Luigi Vitagliano; Alfonso De Simone; Rita Berisio
Journal:  Biophys J       Date:  2013-06-04       Impact factor: 4.033

3.  Structural monitoring of oligosaccharides through 13C enrichment and NMR observation of acetyl groups.

Authors:  Fei Yu; J H Prestegard
Journal:  Biophys J       Date:  2006-06-16       Impact factor: 4.033

4.  Enhanced antimicrobial activity of engineered human lysozyme.

Authors:  Thomas C Scanlon; Charlotte C Teneback; Avinash Gill; Jenna L Bement; Joshua A Weiner; John W Lamppa; Laurie W Leclair; Karl E Griswold
Journal:  ACS Chem Biol       Date:  2010-09-17       Impact factor: 5.100

Review 5.  CH-π Interactions in Glycan Recognition.

Authors:  Laura L Kiessling; Roger C Diehl
Journal:  ACS Chem Biol       Date:  2021-10-06       Impact factor: 4.634

6.  Pattern similarity study of functional sites in protein sequences: lysozymes and cystatins.

Authors:  Shuryo Nakai; Eunice C Y Li-Chan; Jinglie Dou
Journal:  BMC Biochem       Date:  2005-05-18       Impact factor: 4.059

7.  Structural, Functional and Phylogenetic Analysis of Sperm Lysozyme-Like Proteins.

Authors:  Shalini Kalra; Mangottil Ayyappan Pradeep; Ashok K Mohanty; Jai K Kaushik
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

8.  Binding mode analyses and pharmacophore model development for stilbene derivatives as a novel and competitive class of α-glucosidase inhibitors.

Authors:  Yuno Lee; Songmi Kim; Jun Young Kim; Mahreen Arooj; Siu Kim; Swan Hwang; Byeong-Woo Kim; Ki Hun Park; Keun Woo Lee
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.